Skip to main content
Geoffrey Young, MD, General Surgery, Miami, FL

Geoffrey David Young MD PhD, FSSO, FACS

Endocrine, Melanoma, Surgical Oncology (Other than Breast)


Chief, Head and Neck Surgery at Baptist Health Herbert Wertheim Cancer Institute Chair, Dept. Of Surgical Sciences at Florida International University Herbert Wertheim College of Medicine

Request Appointment
  • 8900 N Kendall Dr# MiamiMiami, FL 33176

  • Book by Phone+1(786) 936-3227

  • Fax+1 305-279-7778

Overview of  Dr. Young

Dr. Geoffrey Young is a Head and Neck Surgeon at the Baptist Health Herbert Wertheim Cancer Institute, based in Miami, FL. He is the Chair of the Department of Surgical Sciences at the Florida International University Herbert Wertheim College of Medicine. Dr. Young specializes in Head and Neck Cancer, Thyroid Cancer, and Skin Cancer. He graduated from the University of Alabama School of Medicine in 2006 and completed his surgical residency at Rutgers Health/Robert Wood Johnson Medical School in 2011 followed by a Fellowship in Head and Neck Surgical Oncology at Johns Hopkins. His research contributions are evident in his publications, which have been cited multiple times in reputable journals.

Education & Training

  • Rutgers Health/Robert Wood Johnson Medical School
    Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Surgery, 2006 - 2011
  • University of Alabama School of Medicine
    University of Alabama School of MedicineClass of 2006

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2013 - 2027
  • MD State Medical License
    MD State Medical License 2011 - 2013
  • NJ State Medical License
    NJ State Medical License 2009 - 2011
  • Surgery
    American Board of Surgery Surgery

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification Security Audit Manager, Iatric Systems, Inc., 2014-2017
  • CMS Meaningful Use Stage 2 Certification Access Profiler Enterprise, EMRConnect, 2014-2017
  • CMS Meaningful Use Stage 1 Certification FirstNet, Cerner Corporation, 2014-2017

Publications & Presentations

PubMed

Press Mentions

  • CtDNA Levels Promising for Tracking Melanoma Treatment Progress, Predicting Outcomes
    CtDNA Levels Promising for Tracking Melanoma Treatment Progress, Predicting OutcomesMarch 2nd, 2021

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: